CCG-203971

CAS No. 1443437-74-8

CCG-203971( CCG-203971 | CCG 203971 )

Catalog No. M18020 CAS No. 1443437-74-8

CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
10MG 47 In Stock
25MG 87 In Stock
50MG 152 In Stock
100MG 237 In Stock
500MG 579 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CCG-203971
  • Note
    Research use only, not for human use.
  • Brief Description
    CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
  • Description
    CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971 causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CCG-203971 | CCG 203971
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1443437-74-8
  • Formula Weight
    408.88
  • Molecular Formula
    C23H21ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 155 mg/mL 379.08 mM; H2O : < 0.1 mg/mL
  • SMILES
    O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4
  • Chemical Name
    N-(4-chlorophenyl)-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DNA polymerase-IN-1

    DNA polymerase-IN-1, a DNA polymerase inhibitor, exhibited antiproliferative activity against tumor cells with a half-inhibitory concentration (IC50) of 20.7 μM.

  • Homovanillic acid

    Homovanillic acid is used as a reagent to detect oxidative enzymes, and is associated with dopamine levels in the brain.

  • APE1-IN-1

    APE1-IN-1 is a potent inhibitor of purine/pyrimidine endonuclease 1 (APE1) that crosses the blood-brain barrier, exhibits potential antitumor activity, and enhances the cytotoxicity of the alkylating agent [methyl methanesulfonate] on cancer cells.